Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2024 List of America’s Most Successful Small-Cap Companies
CORAL GABLES, Fla., Dec. 05, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq:CPRX) today announced its inclusion in Forbes’ esteemed list of America’s Most Successful Small-Cap Companies for the year 2024. Catalyst has ranked an impressive 4th out of 100 companies on this prestigious list, which recognizes small-cap companies that have demonstrated positive sales growth over the last twelve months.
Related news for (CPRX)
- Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer
- Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update
- Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025
- Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025
- Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals